Thanks Balance, I have learned a lot on here but I still have a lot to learn. :)
Printable View
There is a meet and greet up in Auckland Wednesday 18th April, Northern Club in Princes St. I assume some of you got the email.
http://www.scientistlive.com/content...ncer-diagnosis
A prospective, multi-centric study involving 577 patients showed the test was extremely reliable, demonstrating a sensitivity of 95% for higher risk cancers and an overall negative predictive value greater than 97%.
ADXBladder is a real game-changer in the field of bladder cancer testing, no requirement for samples to be sent away to specialist labs for analysis.
Can see why Kaiser is in no hurry to do any kind of deal with PEB.
I have just been tested using it. All clear,great test. Bought some shares as a result.
A clear test, that's good news horus1. Congratulations.
But would you not have been happier with the "game changing" ADXBladder test promoted by Balance? Sure ,ADX is not as accurate as the CxBladder suite, but your sample would not have had to suffer the indignity of the trip to the lab.
You follow the drs advice.
Not that far off from the eagerly awaited PEB Investor April 2018 Update.
Last year's theme was "Working with Transformational Customers in the US". https://stocknessmonster.com/announc...eb.nzx-300326/
Specifically, the 'well done the track' progress to obtain CMS coverage and the negotiations underway with Kaiser Permanete to deploy CxBladder to Kaiser's 11 million (yes, million) clients.
Since then, not a sausage of an update from the company which normally shouts out loud the slightest of progress, irrespective of relevance to its cash burn, from the top of Trump tower!
Guess this year's theme will be "Why Investors Need To Be Patient and Why We Need More Time & Money".
For the PEB faithful, reminder that this day next week is when you get to meet, greet and listen to your hero David Darling.
Rumour is that you will be given a cystoscopy on the spot at the meeting if you are thinking of selling out of PEB :D